Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients’ experiences in the era of rapid molecular diagnostic tests

详细信息    查看全文

• 作者：Pren Naidoo ; Margaret van Niekerk ; Elizabeth du Toit…
• 关键词：GenoType MTBDRplus line probe assay ; Xpert® MTB/RIF ; Pathways to care ; Health ; seeking behaviour ; Diagnostic and treatment delay ; Obstacles to care
• 刊名：BMC Health Services Research
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：15
• 期：1
• 全文大小：2,301 KB
• 参考文献：1.World Health Organisation. Global Tuberculosis Report 2013. © World Health Organization 2013. WHO/HTM/TB/2013.11. Available from http://​apps.​who.​int/​iris/​bitstream/​10665/​91355/​1/​9789241564656_​eng.​pdf.​ .
  2.Dowdy DW, Chaisson RE, Maartens G, Corbett EL, Dorman SE. Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testing. Proc Natl Acad Sci U S A. 2008;105:11293–8.PubMedCentral CrossRef PubMed
  3.Dye C. Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis. Nat Rev Microbiol. 2009;7:81–7.CrossRef PubMed
  4.World Health Organisation. Molecular Line Probe Assays For Rapid Screening Of Patients At Risk Of Multidrug-Resistant Tuberculosis, Policy Statement. 2008. Available from http://​www.​who.​int/​tb/​features_​archive/​policy_​statement.​pdf?​ua=​1 .
  5.World Health Organisation. Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB / RIF System. Policy Statement. 2011. © World Health Organization 2011. WHO/HTM/TB/2011.4. Available from http://​apps.​who.​int/​iris/​bitstream/​10665/​44586/​1/​9789241501545_​eng.​pdf .
  6.World Health Organisation. Molecular Line Probe Assays For Rapid Screening Of Patients At Risk Of Multidrug-Resistant Tuberculosis. Expert Group Report. 2008. Available from http://​www.​who.​int/​tb/​features_​archive/​expert_​group_​report_​june08.​pdf .
  7.Jacobson KR, Theron D, Kendall E, Franke MF, Barnard M, van Helden PD, et al. Implementation of genotype MTBDRplus reduces time to multidrug-resistant tuberculosis therapy initiation in South Africa. Clin Infect Dis. 2013;56:503–8.PubMedCentral CrossRef PubMed
  8.Naidoo P, du Toit E, Dunbar R, Lombard C, Caldwell J, Detjen A, et al. A Comparison of Multidrug-Resistant Tuberculosis Treatment Commencement Times in MDRTBPlus Line Probe Assay and Xpert® MTB/RIF-Based Algorithms in a Routine Operational Setting in Cape Town. PLoS One. 2014;9, e103328.PubMedCentral CrossRef PubMed
  9.Dowdy DW, Cattamanchi A, Steingart KR, Pai M. Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosis. PLoS Med. 2011;8, e1001063.PubMedCentral CrossRef PubMed
  10.Finnie RKC, Khoza LB, van den Borne B, Mabunda T, Abotchie P, Mullen PD. Factors associated with patient and health care system delay in diagnosis and treatment for TB in sub-Saharan African countries with high burdens of TB and HIV. Trop Med Int Health. 2011;16:394–411.CrossRef PubMed
  11.Mavhu W, Dauya E, Bandason T, Munyati S, Cowan FM, Hart G, et al. Chronic cough and its association with TB-HIV co-infection: factors affecting help-seeking behaviour in Harare, Zimbabwe. Trop Med Int Health. 2010;15:574–9.PubMedCentral PubMed
  12.Mochache LN, Nyamongo IK. Factors influencing tuberculosis management in rural south-west. Kenya. 2009;13:895–9.
  13.Skordis-Worrall J, Hanson K, Mills A. Confusion, caring and tuberculosis diagnostic delay in Cape Town. South Africa. 2010;14:171–80.
  14.Yimer S, Bjune G, Alene G. Diagnostic and treatment delay among pulmonary tuberculosis patients in Ethiopia: a cross sectional study. BMC Infect Dis. 2005;5:112. doi:10.​1186/​1471-2334-5-112 . Available from: http://​www.​biomedcentral.​com/​1471-2334/​5/​112 . Downloaded 30 April 2013.PubMedCentral CrossRef PubMed
  15.Godfrey-Faussett P, Kaunda H, Kamanga J, van Beers S, van Cleeff M, Kumwenda-Phiri R, et al. Why do patients with a cough delay seeking care at Lusaka urban health centres? A health systems research approach. Int J Tuberc Lung Dis. 2002;6:796–805.PubMed
  16.Cowan J, Greenberg Cowan J, Barnhart S, Demamu S, Fiseha D, Graham W, et al. A qualitative assessment of challenges to tuberculosis management and prevention in Northern Ethiopia. Int J Tuberc lung Dis. 2013;17:1071–5.PubMedCentral CrossRef PubMed
  17.Millen SJ, Uys PW, Hargrove J, van Helden PD, Williams BG. The effect of diagnostic delays on the drop-out rate and the total delay to diagnosis of tuberculosis. PLoS One. 2008;3(4):e1933. doi:10.​1371/​journal.​pone.​0001933 . Downloaded 02 May 2013.PubMedCentral CrossRef PubMed
  18.Mann G, Squire SB, Bissell K, Eliseev P, Du Toit E, Hesseling A, et al. Beyond accuracy : creating a comprehensive evidence base for tuberculosis diagnostic tools. IJTLD. 2010;14:1518–24.
  19.Demissie M, Lindtjorn B, Berhane Y. Patient and health service delay in the diagnosis of pulmonary tuberculosis in Ethiopia. BMC Public Health 2002;2(1):23 Avaialble from http://​www.​biomedcentral.​com/​content/​pdf/​1471-2458-2-23.​pdf .
  20.Lambert ML, Van der Stuyft P. Delays to tuberculosis treatment: shall we continue to blame the victim? Trop Med Int Health. 2005;10:945–6.CrossRef PubMed
  21.Storla DG, Yimer S, Bjune GA. A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health. 2008;8:15. doi:10.​1186/​1471-2458-8-15 . Available from http://​www.​biomedcentral.​com/​1471-2458/​8/​15 . Downloaded 30 April 2013.PubMedCentral CrossRef PubMed
  22.Rajeswari R, Chandrasekaran V, Suhadev M, Sivasubramaniam S, Sudha G, Renu G. Factors associated with patient and health system delays in the diagnosis of tuberculosis in South India. Int J Tuberc Lung Dis. 2002;6:789–95.PubMed
  23.Kasse Y, Jasseh M, Corrah T, Donkor S, Antonnio M, Jallow A, et al. Health seeking behaviour, health system experience and tuberculosis case finding in Gambians with cough. BMC Public Health. 2006;6:143. doi:10.​1186/​1471-2458-6-143 . Available from http://​www.​biomedcentral.​com/​1471-2458/​6/​143 . Downloaded 27 August 2014.PubMedCentral CrossRef PubMed
  24.Luis SF, Kamp N, Mitchell EMH, Henriksen K, van Leth F. Health-seeking norms for tuberculosis symptoms in southern Angola: implications for behaviour change communications. Int J Tuberc Lung Dis. 2011;15:943–8.CrossRef PubMed
  25.Senbeto M, Tadesse S, Tadesse T, Melesse T. Appropriate health-seeking behavior and associated factors among people who had cough for at least two weeks in northwest Ethiopia: a population-based cross-sectional study. BMC Public Health. 2013;13:1222. Available from http://​www.​biomedcentral.​com/​1471-2458/​13/​1222 . Downloaded 27 August 2014.PubMedCentral CrossRef PubMed
  26.Verver S, Warren RM, Beyers N, Richardson M, van der Spuy GD, Borgdorff MW, et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med. 2005;171:1430–5.CrossRef PubMed
  27.Glynn JR, Murray J, Bester A, Nelson G, Shearer S, Sonnenberg P. High rates of recurrence in HIV-infected and HIV-uninfected patients with tuberculosis. J Infect Dis. 2010;201:704–11.CrossRef PubMed
  28.Needham DM, Foster SD, Tomlinson G, Godfrey-Faussett P. Socio-economic, gender and health services factors affecting diagnostic delay for tuberculosis patients in urban Zambia. Trop Med Int Health. 2001;6:256–9.CrossRef PubMed
  29.Pronyk RM, Makhubele MB, Hargreaves JR, Tollman SM, Hausler HP. Assessing health seeking behaviour among tuberculosis patients in rural South Africa. Int J Tuberc Lung Dis. 2001;5:619–27.PubMed
  30.Fochsen G, Deshpande K, Diwan V, Mishra A, Diwan VK, Thorson A. Health care seeking among individuals with cough and tuberculosis: a population-based study from rural India. Int J Tuberc Lung Dis. 2006;10:995–1000.PubMed
  31.Hoa NP, Thorson A, Long NH, Diwan V. Knowledge of tuberculosis and associated health-seeking behaviour among rural Vietnamese adults with a cough for at least three weeks. Scand J Public Health. 2003;31:59–65.CrossRef
  32.Nathanson E, Nunn P, Uplekar M, Floyd K, Jaramillo E, Lönnroth K, et al. MDR Tuberculosis - Critical Steps for Prevention and Control. N Engl J Med. 2010;363:1050–8.CrossRef PubMed
  33.Pope C, Mays N. Qualitative Methods in Health Research. In Qual Res Heal Care. Blackwell Publishing Ltd; 2007; pp1–11.
  34.Lönnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med. 2009;68:2240–6.CrossRef PubMed
  35.Raviglione MC, Pio A. Evolution of WHO policies for tuberculosis control, 1948–2001. Lancet. 2002;359:775–80.CrossRef PubMed
  36.Zumla A, Cobelens F. Operational research and MDG tuberculosis control targets. Lancet Infect Dis. 2012;12:262–3.CrossRef PubMed
  
• 作者单位：Pren Naidoo (1)
  Margaret van Niekerk (1)
  Elizabeth du Toit (1)
  Nulda Beyers (1)
  Natalie Leon (2)
  
  1. Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa
  2. Health Systems Research Unit, South African Medical Research Council, Cape Town, South Africa
  
• 刊物主题：Public Health; Health Administration; Health Informatics; Nursing Management/Nursing Research;
• 出版者：BioMed Central
• ISSN：1472-6963

文摘

Background Although new molecular diagnostic tests such as GenoType MTBDRplus and Xpert® MTB/RIF have reduced multidrug-resistant tuberculosis (MDR-TB) treatment initiation times, patients’ experiences of diagnosis and treatment initiation are not known. This study aimed to explore and compare MDR-TB patients’ experiences of their diagnostic and treatment initiation pathway in GenoType MTBDRplus and Xpert® MTB/RIF-based diagnostic algorithms.